Last updated on April 18, 2014 at 1:21 EDT

Latest N30 Stories

2013-10-15 08:29:53

BOULDER, Colo., Oct. 15, 2013 /PRNewswire/ -- N30 Pharmaceuticals, Inc. today announced presentations regarding its novel portfolio of compounds for the potential treatment of cystic fibrosis at the 2013 North American Cystic Fibrosis Conference, which will be held October 17-19, 2013 in Salt Lake City, Utah. The presentations include preclinical data on its first-in-class inhibitors of S-nitrosoglutathione reductase (GSNORi) and its novel correctors of CFTR, the dysfunctional protein...

2012-10-08 07:23:37

BOULDER, Colo., Oct. 8, 2012 /PRNewswire/ -- N30 Pharmaceuticals, Inc. today announced the addition of Dr. Sherif Gabriel to its senior leadership team. Prior to joining N30 Pharma, Dr. Gabriel was on the faculty of the University of North Carolina Cystic Fibrosis Center, Director of the Cystic Fibrosis Correction Core of the Center, and Associate Professor in the Department of Pediatrics, Division of Pulmonology. Dr. Gabriel's career has revolved around the molecular regulation of ion and...